Author

Claudio Martin

Institution: Instituto Alexander Fleming

Observed institution: Instituto Alexander Fleming

OpenAlex ID: A5137199734

Prognostic value of serial liquid biopsy EGFR mutation monitoring in Hispanic patients with advanced NSCLC treated with osimertinib.

2026 · Juan Manuel Garzon-Dangond, Andres Felipe Cardona, et al. · Journal of Clinical Oncology

Lung cancer screening for early detection of suspicious lung nodules in Latin America (LUCAS-LATAM).

2026 · Luis Corrales, Oscar Arrieta, et al. · Journal of Clinical Oncology

PP01.31: Long-Term Treatment with First-Line Amivantamab Plus Lazertinib: Impact of Treatment Discontinuation, Maintenance, and Early Adverse Event Management on Duration of Therapy

2026 · Danny Nguyen, Alexander I. Spira, et al. · Journal of Thoracic Oncology

Works count: 3

Citation count:

H-index:

I10-index: